Shanghai Yangshan Medical Technology Co., Ltd. has recently announced the successful closure of its Pre-A round financing, raising tens of millions of RMB. This funding round was co-led by prominent investment firms Hillhouse Capital and Vision Knight Capital, with BlueRun Ventures joining as a follow-on investor. Utilizing advanced robotics and artificial intelligence technologies, Yangshan Medical specializes in delivering comprehensive solutions tailored for oral and maxillofacial surgical procedures. The company’s self-developed obstruction-free surgical robot is set to revolutionize oral implant surgery, and its dental implant distractor marks a global innovation. Investors Hang Yuankai from Hillhouse Capital, Tang Yinan from Vision Knight Capital, and representatives from BlueRun Ventures all voiced confidence in Yangshan Medical’s technological capabilities and potential for commercial success. Zhang Shang, the founder of Yangshan Medical, emphasized the company’s commitment to advancing medical digitization. Additionally, the article offers a concise overview of Hillhouse Capital’s investment portfolio and its own corporate background.